Back to news
Veterans Advocate for Cannabis Use Amidst Regulatory Challenges
Cannabis Science Tech<![CDATA[Veterans and Cannabis: Interview with Steve Ellmore]]>

Veterans Advocate for Cannabis Use Amidst Regulatory Challenges

Veterans advocate Steve Ellmore discusses the potential benefits of cannabis for managing chronic pain and the regulatory hurdles that hinder its use

Key Points

  • 1Veterans face challenges in accessing cannabis for pain management
  • 2Cannabis legalization is often used as a political tool
  • 3Research on cannabis's benefits for veterans is lacking
  • 4Ellmore advocates for cannabis as a safer alternative to opioids
  • 5Legislative efforts to allow VA doctors to recommend cannabis have faced setbacks

In a compelling discussion with Cannabis Science and Technology Magazine, Steve Ellmore, a veteran and filmmaker, shed light on the challenges veterans face regarding cannabis use. Ellmore, who founded the documentary project Unprescribed, emphasized the potential benefits of cannabis in managing chronic pain and inflammation, conditions often inadequately addressed by traditional pharmaceuticals. However, he highlighted the lack of substantial research specifically tailored to veterans' needs, which remains a significant hurdle in fully understanding cannabis's therapeutic potential

Ellmore expressed concerns about the political landscape surrounding cannabis legalization, noting that it is often used as a political tool rather than a genuine health initiative. He criticized the current administration for not taking decisive steps towards legalization, suggesting that political figures may lack a genuine understanding of the issue. The involvement of the Drug Enforcement Administration (DEA) in cannabis regulation was also a point of contention, as Ellmore believes that its current use as a crime-busting tool hinders necessary scientific studies

The conversation also touched on the broader implications of cannabis research, with Ellmore advocating for a more focused approach to studying cannabinoids. He pointed out that while there is increasing interest in substances like MDMA and psilocybin for treating PTSD and other conditions, cannabis research is still lagging. Ellmore emphasized the need for more scientific evidence to determine which cannabinoids are most effective for specific medical conditions, arguing that this knowledge is crucial for developing effective treatments

Ellmore's personal experiences with traditional pain management highlight the need for alternative solutions like cannabis. He recounted the adverse effects he faced from long-term use of NSAIDs, which led to severe stomach issues. This experience underscores the potential benefits of cannabis as a safer alternative, given its lack of recorded fatalities and milder side effects compared to opioids and other pharmaceuticals. Ellmore advocates for cannabis as a viable long-term solution for managing chronic pain and mental health issues

Despite legislative setbacks, such as the exclusion of a provision allowing VA doctors to recommend medical cannabis from a recent Senate spending bill, Ellmore remains hopeful. He acknowledged the efforts of veteran organizations in pushing for cannabis access and emphasized the importance of continued advocacy. Ellmore believes that while current legislative actions may seem like mere political promises, the recognition of veterans' needs in these discussions is a positive step forward

Ellmore's insights into the intersection of cannabis use and veteran healthcare highlight the ongoing struggle for comprehensive reform. He argues that without proper legislation and scientific backing, veterans will continue to face barriers in accessing potentially life-changing treatments. The conversation with Madeline Colli underscores the importance of informed advocacy and the need for continued dialogue and research to unlock the full potential of cannabis in veteran healthcare

Share

https://oglab.com/en/news/veterans-advocate-for-cannabis-use-amidst-regulatory-challenges-43eabbea

Want to read more?

Check out more articles and cannabis news